君实生物:2025年营收增长28.23%至24.98亿元,商业化药品销售收入与上年同期相比有所增长

财经网
Mar 16

近日,君实生物发布公告称,2025年君实生物实现营业收入24.98亿元,同比增长28.23%;归属于母公司所有者的净利润亏损8.75亿元,上年同期净利润亏损12.81亿元。公司2025年度不进行利润分配,也不进行资本公积转增股本。营业收入同比增长,主要系商业化药品的销售收入与上年同期相比有所增长。归属于上市公司股东的净利润较上年同期亏损减少主要系商业化药品的销售收入与上年同期相比有所增长。 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10